These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3236795)

  • 61. [Indicators of nonspecific resistance of the body of patients with stomach cancer subjected to different methods of preoperative care].
    Tomashchik EA
    Vestn Khir Im I I Grek; 1984 Aug; 133(8):29-32. PubMed ID: 6388115
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Indices of nonspecific immunity in patients with acute pancreatitis].
    Podil'chak MD; Makar DA; Guliaeva RA; Mats'kiv AS; Vinnichenko BI
    Klin Khir (1962); 1988; (11):61. PubMed ID: 3221649
    [No Abstract]   [Full Text] [Related]  

  • 63. [Class 4 infections. 1) Influenza].
    Kashiwagi S
    Nihon Naika Gakkai Zasshi; 1999 Nov; 88(11):2160-5. PubMed ID: 10590526
    [No Abstract]   [Full Text] [Related]  

  • 64. [State of the factors in nonspecific body protection in 1st-year female students].
    Sautkin MF; Chogovadze AV; Rebrova RN; Gorokhov VI; Leonova GV
    Gig Sanit; 1979 Nov; (11):80-1. PubMed ID: 499870
    [No Abstract]   [Full Text] [Related]  

  • 65. [Indices of body nonspecific reactivity in salmonellosis patients].
    Nagoev BS; Gabrilovich IM
    Ter Arkh; 1987; 59(7):57-61. PubMed ID: 3313784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [How the human body protects itself against the influenza virus].
    Shvartsman IaS
    Med Sestra; 1984 Mar; 43(3):13-6. PubMed ID: 6562340
    [No Abstract]   [Full Text] [Related]  

  • 67. [Dynamics of certain indicators of nonspecific defense in patients with influenza].
    Stadnik LM
    Vrach Delo; 1974 Jan; (1):137-8. PubMed ID: 4468563
    [No Abstract]   [Full Text] [Related]  

  • 68. [Indices of nonspecific resistance of the body in patients with influenza].
    Nagoev BS
    Klin Med (Mosk); 1988 Nov; 66(11):118-22. PubMed ID: 3236795
    [No Abstract]   [Full Text] [Related]  

  • 69. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 70. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influenza vaccine: the challenge of antigenic drift.
    Carrat F; Flahault A
    Vaccine; 2007 Sep; 25(39-40):6852-62. PubMed ID: 17719149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influenza: consideration of pandemics.
    Sanford JP
    Adv Intern Med; 1969; 15():419-53. PubMed ID: 4914608
    [No Abstract]   [Full Text] [Related]  

  • 73. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.